研究稳心颗粒联合倍他乐克在治疗冠心病快速心律失常中的临床疗效

To Study the Clinical Efficacy of Wenxin Granule Combined with Betaloc in the Treatment of Coronary Heart Disease with Rapid Arrhythmia

目的试论在临床对冠心病快速心律失常患者中应用稳心颗粒+倍他乐克联合治疗的临床现实意义。方法随机抽选于2014年6月至2018年6月我院顺利收治的173例冠心病快速心律失常患者,根据就诊顺序及不同给药方式分组。联合组(n=87)应用稳心颗粒+倍他乐克联合治疗,参照组(n=86)单一应用倍他乐克。将两组的药物效果、24h动态心电图变化情况进行评价与比较。结果联合组的药物效果明显要比参照组更强(P<0.05);相比于参照组,联合组的24h动态心电图得到明显改善(P<0.05)。结论在临床对冠心病快速心律失常患者中应用稳心颗粒+倍他乐克联合治疗,可实现药物作用最大化,有效减少快速心律失常发作次数,缓解临床病症,对预防与控制病情进展具有积极作用。

Objective To investigate the clinical significance of the combination of Wenxin granules and Betaloc in the treatment of patients with coronary heart disease and tachyarrhythmia. Methods 173 cases of CHD patients were randomly selected from June 2014 to June 2018 in our hospital. The patients were grouped according to the order of treatment and different modes of administration. The combined group（n =87） was treated with Wenxin Granule plus Betaloc. The reference group（n =86） is a single application of Betaloc. Two groups of drug effects, 24 h dynamic ECG changes were evaluated and compared. Results The drug effect of the combined group was significantly stronger than that of the reference group（P〈 0.05）. Compared with the reference group, the 24 h dynamic electrocardiogram of the combined group was significantly improved（P〈 0.05）. Conclusion In the clinical treatment of patients with coronary heart disease and tachyarrhythmia, relieve clinical symptoms, and prevent and control the progression of the disease. positive effects.